HealthRSS

  • March 22, 2007

    Permanent Injunction Ends Topamax Patent Fight

    A federal judge on Tuesday issued a final judgment in favor of Ortho-McNeil Pharmaceutical Inc. in the company’s patent infringement fight over a generic version of its blockbuster epilepsy drug.

  • March 22, 2007

    Amgen Asks High Court To Hear Landmark Case

    Seeking a high profile review of the 12-year old Markman rule, biotech company Amgen Inc. asked the U.S. Supreme Court on Thursday to decide whether a federal appeals court should give deference to findings made by a trial court during claim construction.

  • March 22, 2007

    Holland Snags Former Illinois AG Senior Counsel

    Holland & Knight LLP has bolstered its national health law practice with the addition of Anne Murphy as partner and chair of its Chicago health law team, marking its eighth acquisition in the past year.

  • March 22, 2007

    Shire Ensnares Another Generic Co. Over Adderall

    Drug maker Shire PLC has added to its hit list of generic drug companies, claiming Actavis Group hf infringed its patents covering hyperactivity drug Adderall XR.

  • March 21, 2007

    Takeda Wins $16.8M In Fees For Misconduct

    A U.S. federal judge has ordered two generic drug makers to pay $16.8 million in legal fees to Takeda Pharmaceutical Co Ltd. for their “exceptional misconduct and bad faith” during a patent challenge last year.

  • March 21, 2007

    FDA Proposes Tougher Guidelines For Advisers

    The U.S. Food and Drug Administration released draft guidelines Wednesday that would keep individuals with interests of over $50,000 in drug and medical device companies from participating in the agency’s advisory committees.

  • March 21, 2007

    Oxfam Slams Abbott Over Thailand Standoff

    Charity group Oxfam International has blasted Abbott Laboratories for its recent decision to halt the launch of new medicines in Thailand, urging the pharmaceutical giant not to “abandon the sick people in Thailand.”

  • March 21, 2007

    Barr Sued Over Plan For Schizophrenia Drug

    Japanese drug maker Otsuka Pharmaceutical Co. Ltd. has filed a patent infringement lawsuit against Barr Pharmaceuticals Inc. over its plan to manufacture a generic version of Otsuka’s schizophrenia drug, Abilify.

  • March 21, 2007

    Pfizer Whistleblower Challenges Claim Dismissal

    A former marketing vice president at Pfizer Inc. is appealing the dismissal of his whistleblower lawsuit accusing the pharmaceutical giant of illegally marketing a successful biotechnology drug, human growth hormone Genotropin.

  • March 20, 2007

    Pfizer Wins Celebrex Challenge

    A New Jersey federal court has rejected a challenge by Israeli generics maker Teva Pharmaceuticals to Pfizer’s blockbuster painkiller Celebrex, Pfizer said Tuesday.

  • March 20, 2007

    AMA Asks DOJ To Block UnitedHealth Merger

    A prominent doctors’ group has asked the U.S. Department of Justice to block UnitedHealth Group Inc.’s proposed $2.6 billion takeover of Sierra Health Services, claiming it will give the health care company a monopoly in Nevada.

  • March 20, 2007

    Medtronic Wins Appeal Over Spinal Technology

    In a blow to Biomet Inc., a federal appeals court ruled Tuesday in favor of rival medical device maker Medtronic in a dispute over patents covering spinal surgery.

  • March 20, 2007

    Cardinal Health Sued Over Tissue Implant Patents

    A Texas-based medical device company filed a patent infringement suit Monday against Cardinal Health Inc. and Allegiance Corp. over medical devices used to strengthen bones.

  • March 20, 2007

    Interest Group Has No Standing In Medicare Suit

    A court has denied a preliminary injunction sought by a public interest law firm against the enforcing of bans on health care providers promoting one Medicare plan over another, ruling the organization has no standing to sue.

  • March 19, 2007

    Milberg Weiss Class Action Bid Denied

    A district court judge has struck another blow to embattled law firm Milberg Weiss & Bershad LLP, which was ruled inadequate to act as sole lead counsel in a proposed class action securities case against health company Organogenesis.

  • March 19, 2007

    Court Upholds FDA Ban On Diet Pills

    A court has denied a demand by health food maker Nutraceutical Corp to lift the U.S. drug agency’s blanket ban on its dietary supplements.

  • March 19, 2007

    High Court Seeks U.S. Opinion On Tamoxifen Case

    Continuing to mull whether to weigh in on the issue of authorized generics, the U.S. Supreme Court asked the federal government Monday for its opinion on whether the judicial body should hear the Tamoxifen Citrate antitrust lawsuits.

  • March 19, 2007

    Alexion's Soliris Blood Drug Draws New Patent Cases

    Just days after Alexion Pharmaceuticals Inc.’s blood antibody drug Soliris was approved by the United States Food and Drug Administration, two parties have filed a lawsuit claiming the drug infringes on their patents.

  • March 19, 2007

    Ex-Scrushy Bodyguard Wins $1.9M

    A security officer at HealthSouth Corp. who was fired along with the company’s embattled CEO has won a wrongful termination suit against the company, a verdict that came with a $1.9 million payday.

  • March 19, 2007

    Medtronic Sues Cordis In New Stent Dispute

    Prolonging a drawn-out legal battle over stent technology, medical device maker Medtronic Inc. has filed a new patent infringement lawsuit against Johnson & Johnson subsidiary Cordis Corp.